Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes

B Sharma, N Singh - Current neurovascular research, 2010 - ingentaconnect.com
Diabetes has been found to increase the probability of vascular dementia in humans. We
have investigated the effect of 4'-hydroxy-3'-methoxyacetophenone (HMAP), a NADPH …
被引用次数：75 相关文章

Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes.

B Sharma, N Singh - Current Neurovascular Research, 2010 - europepmc.org
Diabetes has been found to increase the probability of vascular dementia in humans. We
have investigated the effect of 4'-hydroxy-3'-methoxyacetophenone (HMAP), a NADPH …

Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes

B Sharma, N Singh - Current Neurovascular Research, 2010 - hero.epa.gov
Diabetes has been found to increase the probability of vascular dementia in humans. We
have investigated the effect of 4'-hydroxy-3'-methoxyacetophenone (HMAP), a NADPH …

Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes

B Sharma, N Singh - Current neurovascular research, 2010 - pubmed.ncbi.nlm.nih.gov
Diabetes has been found to increase the probability of vascular dementia in humans. We
have investigated the effect of 4'-hydroxy-3'-methoxyacetophenone (HMAP), a NADPH …